EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia

Mireia Saballs, Sandra Parra, Neus Martínez, Nuria Amigo, Lydia Cabau, Simona Iftimie, Raul Pavon, Xavi Gabaldó, Xavier Correig, Silvia Paredes, Josep Maria Vallvé, Antoni Castro

Journal of Lipid Research · 2024

DOI: 10.1016/j.jlr.2024.100622 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Mireia Saballs und 11 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Quiron Salud Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: COVID-19, Community-Acquired Infections, Lipidomics. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This prospective observational study compared the 1H NMR blood lipidomes and metabolomes of 71 patients with community-acquired pneumonia (CAP), 75 patients with COVID-19 pneumonia, and 75 healthy controls (matched by age and sex) to identify potential biomarkers and pathways associated with respiratory infections. Both pneumonia groups had comparable severity indices, including mortality, invasive mechanical ventilation, and intensive care unit admission rates. Patients with COVID-19 pneumonia exhibited more pronounced hypolipidemia, with significantly lower levels of total cholesterol and LDL-c compared to patients with CAP. Atherogenic lipoprotein subclasses (VLDL-cholesterol, IDL-cholesterol, IDL-triglyceride, and LDL-triglyceride/LDL-cholesterol) were significantly increased in severe cases of both pneumonia types, while lower HDL-c and small, dense HDL particles were associated with more severe illness. Both infected groups showed decreased esterified cholesterol and increased triglycerides, along with reduced phosphatidylcholine, lysophosphatidylcholine, PUFA, omega-3 fatty acids, and DHA. Additionally, infected patients had elevated levels of glucose, lactate, 3-hydroxybutyrate, and acetone, which are linked to inflammation, hypoxemia, and sepsis. Increased levels of branched-chain amino acids, alanine, glycine, and creatine, which are involved in energy metabolism and protein catabolism, were also observed. Neurotransmitter synthesis metabolites like histidine and glutamate were higher in infected patients, especially those with COVID-19. Notably, severe infections showed a significant decrease in glutamine, essential for lymphocyte and macrophage energy. The severity of COVID-19 pneumonia was also associated with elevated glycoprotein levels (glycoprotein A, glycoprotein B, and glycoprotein F), indicating an inflammatory state. These findings suggest that metabolomic and lipidomic changes in pneumonia are connected to bioenergetic pathways regulating the immune response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Community-Acquired InfectionsLipidomicsHumansMaleFemaleMiddle AgedAgedProspective StudiesMetabolomicsSARS-CoV-2MetabolomeBiomarkers

Stichwörter der Autor:innen

COVID-19HDLNMRlipidomicsmetabolomicspneumonia

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Internal Medicine Department, Quiron Salud Hospital, Barcelona, Spain.
  • Research Group of Autoimmunity, Infection and Thrombosis (GRAIIT), Pere Virgili for Health Research Institute (IISPV), Rovira and Virgili University (URV), Reus, Spain; Internal Medicine Department, "Sant Joan" Universi…
  • Biosfer Teslab, Reus, Spain; Department of Basic Medical Sciences, Rovira and Virgili University (URV), Pere Virgili for Health Research Institute (IISPV), Tarragona, Spain.
  • Biosfer Teslab, Reus, Spain; Department of Basic Medical Sciences, Rovira and Virgili University (URV), Pere Virgili for Health Research Institute (IISPV), Tarragona, Spain; Centre for Biomedical Research Network on Dia…
  • Research Group of Autoimmunity, Infection and Thrombosis (GRAIIT), Pere Virgili for Health Research Institute (IISPV), Rovira and Virgili University (URV), Reus, Spain; Clinical laboratory Department, "Sant Joan" Univer…
  • Centre for Biomedical Research Network on Diabetes and Associated Metabolic Diseases (CIBERDEM), ISCIII, Madrid, Spain; Department of Electronic Engineering, Rovira and Virgili University (URV), Institut d'Investigació…

Förderung

  • European Commission
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Instituto de Salud Carlos III

Zitieren

APA

Saballs, M., Parra, S., Martínez, N., Amigo, N., Cabau, L., Iftimie, S., Pavon, R., Gabaldó, X., Correig, X., Paredes, S., Vallvé, J. M., & Castro, A. (2024). Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100622

Vancouver

Saballs M, Parra S, Martínez N, Amigo N, Cabau L, Iftimie S, et al. Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100622

BibTeX
@article{Saballs2024,
  author = {Saballs, Mireia and Parra, Sandra and Martínez, Neus and Amigo, Nuria and Cabau, Lydia and Iftimie, Simona and Pavon, Raul and Gabaldó, Xavi and Correig, Xavier and Paredes, Silvia and Vallvé, Josep Maria and Castro, Antoni},
  title = {Lipidomic and metabolomic changes in community-acquired and COVID-19 pneumonia},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2024.100622}
}
Kostenlos starten →